The Extracellular Matrix

May 18, 2015 Zac Riggs

I would like to begin this discussion with an interesting observation published in Science 2003 by Mary Claire King, the lead researcher who discovered the BRCA 1 and 2 genetic mutations. The lifetime risk for being diagnosed with breast cancer among female BRCA mutation carriers is currently 82%. If a carrier was born before 1940, her risk for breast cancer was 24% by the age of 50. Contrast this to a carrier born after 1940, who was found to have a 67% risk of breast cancer by age 50. How does traditional medicine, using the conventional cell mutation theory of...